Request Demo
Last update 20 Mar 2025
DXC-008
Last update 20 Mar 2025
Overview
Basic Info
Drug Type Antibody drug conjugate (ADC) |
Synonyms |
Target |
Action inhibitors |
Mechanism PSMA inhibitors(Prostate-specific membrane antigen inhibitors), STEAP1 inhibitors(Six-transmembrane epithelial antigen of the prostate 1 inhibitors), Tubulin inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Boost your research with our ADC technology data.
login
or
Related
1
Clinical Trials associated with DXC-008CTR20250917
评估注射用DXC008在前列腺癌、尤文肉瘤等多种实体肿瘤中的安全性、耐受性、药代动力学特征以及初步疗效的开放、多中心、首次人体、剂量递增和扩大入组的I期临床研究。
[Translation] An open, multicenter, first-in-human, dose-escalation and expanded Phase I clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of DXC008 for injection in various solid tumors such as prostate cancer and Ewing sarcoma.
100 Clinical Results associated with DXC-008
Login to view more data
100 Translational Medicine associated with DXC-008
Login to view more data
100 Patents (Medical) associated with DXC-008
Login to view more data
100 Deals associated with DXC-008
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Ewing Sarcoma | Phase 1 | China | 18 Mar 2025 | |
| Metastatic castration-resistant prostate cancer | Phase 1 | China | 18 Mar 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free